Variant report
Variant | nsv519549 |
---|---|
Chromosome Location | chr8:69682388-69687852 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:69489517..69490141-chr8:69685805..69686684,3 | MCF-7 | breast: | |
2 | chr8:69648438..69649075-chr8:69686043..69686623,2 | MCF-7 | breast: | |
3 | chr8:69489841..69490343-chr8:69685997..69686537,2 | MCF-7 | breast: | |
4 | chr8:69684482..69688368-chr8:69762278..69766064,4 | MCF-7 | breast: | |
5 | chr8:69684731..69687775-chr8:69763630..69766534,4 | MCF-7 | breast: | |
6 | chr8:69488341..69491069-chr8:69684855..69686356,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254337 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4278138 | chr8:69682388-69682389 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143058403 | chr8:69682403-69682404 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146154880 | chr8:69682426-69682427 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117298313 | chr8:69682438-69682439 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138508863 | chr8:69682449-69682450 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532800742 | chr8:69682464-69682465 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552895180 | chr8:69682468-69682469 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558658153 | chr8:69682500-69682501 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4427154 | chr8:69682524-69682525 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs369957423 | chr8:69682547-69682548 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188288038 | chr8:69682556-69682557 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141160014 | chr8:69682562-69682563 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193188782 | chr8:69682572-69682573 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553541668 | chr8:69682591-69682592 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs60347737 | chr8:69682592-69682593 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs542440212 | chr8:69682631-69682632 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185417928 | chr8:69682700-69682701 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575995466 | chr8:69682810-69682811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189407331 | chr8:69682835-69682836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543473331 | chr8:69682873-69682874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs4351405 | chr8:69682892-69682893 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs191090703 | chr8:69682919-69682920 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183644126 | chr8:69682986-69682987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188302805 | chr8:69682987-69682988 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4299986 | chr8:69683021-69683022 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs557871363 | chr8:69683043-69683044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181256314 | chr8:69683044-69683045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533742448 | chr8:69683068-69683069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553735211 | chr8:69683080-69683081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574212522 | chr8:69683083-69683084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115974145 | chr8:69683236-69683237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556632971 | chr8:69683343-69683344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374136648 | chr8:69683380-69683381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372313430 | chr8:69683412-69683413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112822064 | chr8:69683422-69683423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186696561 | chr8:69683472-69683473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189936753 | chr8:69683477-69683478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565002161 | chr8:69683525-69683526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527799826 | chr8:69683537-69683538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150736969 | chr8:69683557-69683558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561342701 | chr8:69683558-69683559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530079653 | chr8:69683598-69683599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182048595 | chr8:69683608-69683609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560123809 | chr8:69683639-69683640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569091503 | chr8:69683660-69683661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186354678 | chr8:69683666-69683667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551624599 | chr8:69683695-69683696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191052153 | chr8:69683703-69683704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73683711 | chr8:69683708-69683709 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs139079545 | chr8:69683732-69683733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
head and neck squamous cell carcinoma | 16715129 | CNVD |
Prostate cancer | 16461572 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Chordoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:69675200-69686200 | Weak transcription | Fetal Lung | lung |
2 | chr8:69680400-69682600 | Weak transcription | NHLF | lung |
3 | chr8:69680600-69682600 | Weak transcription | HSMM | muscle |
4 | chr8:69680600-69682600 | Weak transcription | Osteobl | bone |
5 | chr8:69681200-69682600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr8:69682000-69683000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr8:69682200-69682800 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr8:69682600-69683800 | Enhancers | NHLF | lung |
9 | chr8:69682600-69684000 | Enhancers | HSMM | muscle |
10 | chr8:69682600-69684400 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr8:69682600-69684400 | Enhancers | Osteobl | bone |
12 | chr8:69682800-69684200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr8:69682800-69684400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr8:69683000-69688000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr8:69686000-69686400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr8:69686000-69686400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr8:69686200-69687000 | Enhancers | Fetal Lung | lung |
18 | chr8:69687000-69687600 | Weak transcription | Fetal Lung | lung |
19 | chr8:69687600-69687800 | Enhancers | Fetal Lung | lung |
20 | chr8:69687800-69689400 | Weak transcription | Fetal Lung | lung |